| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0089 | 0.9 |